CAR T Cell Therapy Market Report

Europe CAR T Cell Therapy Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 26, 2019
  • PAGES：200
  • REPORT CODE：GMM354464
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The CAR T Cell Therapy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe CAR T Cell Therapy Market Segmentations:

    By Player:

    • Gilead Sciences Inc

    • Cellectis

    • Celgene Corporation

    • Juno Therapeutics

    • Pfizer, Inc.

    • Bellicum Pharmaceuticals, Inc.

    • Kite Pharma, Inc.

    By Type:

    • CD 19

    • CD 20

    • GD2

    • CD22

    • CD30

    • CD33

    • HER1

    • HER2

    • Meso

    • EGFRvlll

    By End-User:

    • Acute Lymphocytic

    • Leukemia

    • Chronic Lymphocytic Leukemia

    • Non Hodgkin Leukemia

    • Multiple Myeloma

    • Pancreatic Cancer

    • Neuroblasta

    • Breast Cancer

    • Acute Myeloid Leukemia

    • Hepatocellular Carcinoma

    • Colorectal Cancer

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of CAR T Cell Therapy Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe CAR T Cell Therapy Market Size and Growth Rate of CD 19 from 2014 to 2026

    • 1.3.2 Europe CAR T Cell Therapy Market Size and Growth Rate of CD 20 from 2014 to 2026

    • 1.3.3 Europe CAR T Cell Therapy Market Size and Growth Rate of GD2 from 2014 to 2026

    • 1.3.4 Europe CAR T Cell Therapy Market Size and Growth Rate of CD22 from 2014 to 2026

    • 1.3.5 Europe CAR T Cell Therapy Market Size and Growth Rate of CD30 from 2014 to 2026

    • 1.3.6 Europe CAR T Cell Therapy Market Size and Growth Rate of CD33 from 2014 to 2026

    • 1.3.7 Europe CAR T Cell Therapy Market Size and Growth Rate of HER1 from 2014 to 2026

    • 1.3.8 Europe CAR T Cell Therapy Market Size and Growth Rate of HER2 from 2014 to 2026

    • 1.3.9 Europe CAR T Cell Therapy Market Size and Growth Rate of Meso from 2014 to 2026

    • 1.3.10 Europe CAR T Cell Therapy Market Size and Growth Rate of EGFRvlll from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe CAR T Cell Therapy Market Size and Growth Rate of Acute Lymphocytic from 2014 to 2026

    • 1.4.2 Europe CAR T Cell Therapy Market Size and Growth Rate of Leukemia from 2014 to 2026

    • 1.4.3 Europe CAR T Cell Therapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia from 2014 to 2026

    • 1.4.4 Europe CAR T Cell Therapy Market Size and Growth Rate of Non Hodgkin Leukemia from 2014 to 2026

    • 1.4.5 Europe CAR T Cell Therapy Market Size and Growth Rate of Multiple Myeloma from 2014 to 2026

    • 1.4.6 Europe CAR T Cell Therapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

    • 1.4.7 Europe CAR T Cell Therapy Market Size and Growth Rate of Neuroblasta from 2014 to 2026

    • 1.4.8 Europe CAR T Cell Therapy Market Size and Growth Rate of Breast Cancer from 2014 to 2026

    • 1.4.9 Europe CAR T Cell Therapy Market Size and Growth Rate of Acute Myeloid Leukemia from 2014 to 2026

    • 1.4.10 Europe CAR T Cell Therapy Market Size and Growth Rate of Hepatocellular Carcinoma from 2014 to 2026

    • 1.4.11 Europe CAR T Cell Therapy Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of CAR T Cell Therapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of CAR T Cell Therapy by Major Types

      • 3.4.1 Market Size and Growth Rate of CD 19

      • 3.4.2 Market Size and Growth Rate of CD 20

      • 3.4.3 Market Size and Growth Rate of GD2

      • 3.4.4 Market Size and Growth Rate of CD22

      • 3.4.5 Market Size and Growth Rate of CD30

      • 3.4.6 Market Size and Growth Rate of CD33

      • 3.4.7 Market Size and Growth Rate of HER1

      • 3.4.8 Market Size and Growth Rate of HER2

      • 3.4.9 Market Size and Growth Rate of Meso

      • 3.4.10 Market Size and Growth Rate of EGFRvlll

    4 Segmentation of CAR T Cell Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of CAR T Cell Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of CAR T Cell Therapy for Acute Lymphocytic

      • 4.4.2 Market Size and Growth Rate of CAR T Cell Therapy for Leukemia

      • 4.4.3 Market Size and Growth Rate of CAR T Cell Therapy for Chronic Lymphocytic Leukemia

      • 4.4.4 Market Size and Growth Rate of CAR T Cell Therapy for Non Hodgkin Leukemia

      • 4.4.5 Market Size and Growth Rate of CAR T Cell Therapy for Multiple Myeloma

      • 4.4.6 Market Size and Growth Rate of CAR T Cell Therapy for Pancreatic Cancer

      • 4.4.7 Market Size and Growth Rate of CAR T Cell Therapy for Neuroblasta

      • 4.4.8 Market Size and Growth Rate of CAR T Cell Therapy for Breast Cancer

      • 4.4.9 Market Size and Growth Rate of CAR T Cell Therapy for Acute Myeloid Leukemia

      • 4.4.10 Market Size and Growth Rate of CAR T Cell Therapy for Hepatocellular Carcinoma

      • 4.4.11 Market Size and Growth Rate of CAR T Cell Therapy for Colorectal Cancer

    5 Market Analysis by Major Regions

    • 5.1 Europe CAR T Cell Therapy Production Analysis by Top Regions

    • 5.2 Europe CAR T Cell Therapy Consumption Analysis by Top Regions

    • 5.3 Europe CAR T Cell Therapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.2 UK CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.3 France CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    6 Product Circulation of CAR T Cell Therapy Market among Top Countries

    • 6.1 Top 5 Export Countries in CAR T Cell Therapy Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in CAR T Cell Therapy Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in CAR T Cell Therapy Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in CAR T Cell Therapy Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in CAR T Cell Therapy Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in CAR T Cell Therapy Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany CAR T Cell Therapy Landscape Analysis

    • 7.1 Germany CAR T Cell Therapy Landscape Analysis by Major Types

    • 7.2 Germany CAR T Cell Therapy Landscape Analysis by Major End-Users

    8. UK CAR T Cell Therapy Landscape Analysis

    • 8.1 UK CAR T Cell Therapy Landscape Analysis by Major Types

    • 8.2 UK CAR T Cell Therapy Landscape Analysis by Major End-Users

    9. France CAR T Cell Therapy Landscape Analysis

    • 9.1 France CAR T Cell Therapy Landscape Analysis by Major Types

    • 9.2 France CAR T Cell Therapy Landscape Analysis by Major End-Users

    10. Italy CAR T Cell Therapy Landscape Analysis

    • 10.1 Italy CAR T Cell Therapy Landscape Analysis by Major Types

    • 10.2 Italy CAR T Cell Therapy Landscape Analysis by Major End-Users

    11. Spain CAR T Cell Therapy Landscape Analysis

    • 11.1 Spain CAR T Cell Therapy Landscape Analysis by Major Types

    • 11.2 Spain CAR T Cell Therapy Landscape Analysis by Major End-Users

    12. Poland CAR T Cell Therapy Landscape Analysis

    • 12.1 Poland CAR T Cell Therapy Landscape Analysis by Major Types

    • 12.2 Poland CAR T Cell Therapy Landscape Analysis by Major End-Users

    13. Russia CAR T Cell Therapy Landscape Analysis

    • 13.1 Russia CAR T Cell Therapy Landscape Analysis by Major Types

    • 13.2 Russia CAR T Cell Therapy Landscape Analysis by Major End-Users

    14. Switzerland CAR T Cell Therapy Landscape Analysis

    • 14.1 Switzerland CAR T Cell Therapy Landscape Analysis by Major Types

    • 14.2 Switzerland CAR T Cell Therapy Landscape Analysis by Major End-Users

    15. Turkey CAR T Cell Therapy Landscape Analysis

    • 15.1 Turkey CAR T Cell Therapy Landscape Analysis by Major Types

    • 15.2 Turkey CAR T Cell Therapy Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Landscape Analysis by Top Countries

      • 16.3.1 Denmark CAR T Cell Therapy Market Volume and Growth Rate

      • 16.3.2 Finland CAR T Cell Therapy Market Volume and Growth Rate

      • 16.3.3 Norway CAR T Cell Therapy Market Volume and Growth Rate

      • 16.3.4 Sweden CAR T Cell Therapy Market Volume and Growth Rate

      • 16.3.6 Iceland CAR T Cell Therapy Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Landscape Analysis by Top Countries

      • 17.3.1 Belgium CAR T Cell Therapy Market Volume and Growth Rate

      • 17.3.2 Netherlands CAR T Cell Therapy Market Volume and Growth Rate

      • 17.3.3 Luxembourg CAR T Cell Therapy Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Landscape Analysis by Top Countries

      • 18.3.1 Estonia CAR T Cell Therapy Market Volume and Growth Rate

      • 18.3.2 Latvia CAR T Cell Therapy Market Volume and Growth Rate

      • 18.3.3 Lithuania CAR T Cell Therapy Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Gilead Sciences Inc

      • 19.1.1 Gilead Sciences Inc Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Cellectis

      • 19.2.1 Cellectis Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Celgene Corporation

      • 19.3.1 Celgene Corporation Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Juno Therapeutics

      • 19.4.1 Juno Therapeutics Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Pfizer, Inc.

      • 19.5.1 Pfizer, Inc. Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Bellicum Pharmaceuticals, Inc.

      • 19.6.1 Bellicum Pharmaceuticals, Inc. Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Kite Pharma, Inc.

      • 19.7.1 Kite Pharma, Inc. Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    The List of Tables and Figures (Totals 108 Figures and 151 Tables)

    • Figure Product Picture

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of CD 19 from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of CD 20 from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of GD2 from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of CD22 from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of CD30 from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of CD33 from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of HER1 from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of HER2 from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Meso from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of EGFRvlll from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Acute Lymphocytic from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Leukemia from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Non Hodgkin Leukemia from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Multiple Myeloma from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Neuroblasta from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Breast Cancer from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Acute Myeloid Leukemia from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Hepatocellular Carcinoma from 2014 to 2026

    • Figure Europe CAR T Cell Therapy Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

    • Figure Germany CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure UK CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure France CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Italy CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Spain CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Poland CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Russia CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Canada CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Finland CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Norway CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania CAR T Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of CAR T Cell Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of CAR T Cell Therapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of CAR T Cell Therapy by Different Types from 2014 to 2026

    • Table Consumption Share of CAR T Cell Therapy by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of CD 19

    • Figure Market Size and Growth Rate of CD 20

    • Figure Market Size and Growth Rate of GD2

    • Figure Market Size and Growth Rate of CD22

    • Figure Market Size and Growth Rate of CD30

    • Figure Market Size and Growth Rate of CD33

    • Figure Market Size and Growth Rate of HER1

    • Figure Market Size and Growth Rate of HER2

    • Figure Market Size and Growth Rate of Meso

    • Figure Market Size and Growth Rate of EGFRvlll

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of CAR T Cell Therapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of CAR T Cell Therapy by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Acute Lymphocytic

    • Figure Market Size and Growth Rate of Leukemia

    • Figure Market Size and Growth Rate of Chronic Lymphocytic Leukemia

    • Figure Market Size and Growth Rate of Non Hodgkin Leukemia

    • Figure Market Size and Growth Rate of Multiple Myeloma

    • Figure Market Size and Growth Rate of Pancreatic Cancer

    • Figure Market Size and Growth Rate of Neuroblasta

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Acute Myeloid Leukemia

    • Figure Market Size and Growth Rate of Hepatocellular Carcinoma

    • Figure Market Size and Growth Rate of Colorectal Cancer

    • Table Europe CAR T Cell Therapy Production by Major Regions

    • Table Europe CAR T Cell Therapy Production Share by Major Regions

    • Figure Europe CAR T Cell Therapy Production Share by Major Countries and Regions in 2014

    • Table Europe CAR T Cell Therapy Consumption by Major Regions

    • Table Europe CAR T Cell Therapy Consumption Share by Major Regions

    • Table Germany CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table UK CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table France CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Italy CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Spain CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Poland CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Russia CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Switzerland CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Turkey CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in CAR T Cell Therapy Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in CAR T Cell Therapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in CAR T Cell Therapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in CAR T Cell Therapy Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table Germany CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Germany CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Germany CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table UK CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table UK CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table UK CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table UK CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table France CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table France CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table France CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table France CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Italy CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table Italy CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Italy CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Italy CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Spain CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table Spain CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Spain CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Spain CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Poland CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table Poland CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Poland CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Poland CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Russia CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table Russia CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Russia CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Russia CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table Switzerland CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Switzerland CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Switzerland CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Turkey CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table Turkey CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Turkey CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Turkey CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) CAR T Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) CAR T Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) CAR T Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries CAR T Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Gilead Sciences Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences Inc

    • Figure Sales and Growth Rate Analysis of Gilead Sciences Inc

    • Figure Revenue and Market Share Analysis of Gilead Sciences Inc

    • Table Product and Service Introduction of Gilead Sciences Inc

    • Table Company Profile and Development Status of Cellectis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis

    • Figure Sales and Growth Rate Analysis of Cellectis

    • Figure Revenue and Market Share Analysis of Cellectis

    • Table Product and Service Introduction of Cellectis

    • Table Company Profile and Development Status of Celgene Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

    • Figure Sales and Growth Rate Analysis of Celgene Corporation

    • Figure Revenue and Market Share Analysis of Celgene Corporation

    • Table Product and Service Introduction of Celgene Corporation

    • Table Company Profile and Development Status of Juno Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics

    • Figure Sales and Growth Rate Analysis of Juno Therapeutics

    • Figure Revenue and Market Share Analysis of Juno Therapeutics

    • Table Product and Service Introduction of Juno Therapeutics

    • Table Company Profile and Development Status of Pfizer, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc.

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc.

    • Figure Revenue and Market Share Analysis of Pfizer, Inc.

    • Table Product and Service Introduction of Pfizer, Inc.

    • Table Company Profile and Development Status of Bellicum Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bellicum Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Bellicum Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Bellicum Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Bellicum Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Kite Pharma, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma, Inc.

    • Figure Sales and Growth Rate Analysis of Kite Pharma, Inc.

    • Figure Revenue and Market Share Analysis of Kite Pharma, Inc.

    • Table Product and Service Introduction of Kite Pharma, Inc.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US